Percutaneous catheter-based transluminal renal nerve ablation (RNA) by delivery of
radiofrequency energy constitutes a novel therapeutic strategy for the treatment of resistant …

Resistant hypertension is frequently encountered and remains challenging in everyday
clinical practice despite the availability of numerous effective antihypertensive drugs …

Approximately 10% of patients with hypertension have resistant hypertension, even if
adequate pharmacological therapy is established. In this regard, renal nerve ablation (RNA) …

Aims: The primary objective of this prospective, randomized trial was to determine the BP-
lowering efficacy of percutaneous RNA for seated office systolic BP (SBP) in patients with …

This review aims to describe the role and the results of catheter-based renal nerve ablation
for the treatment of resistant hypertension. Despite the availability of multiple classes of …

Among current epidemics, chronic kidney disease (CKD) is accompanied with high
morbidity and mortality rates inherently associated with the thriving comorbidities of …

INTRODUCTION: Resistant hypertension is a common and growing clinical problem
characterized by the failure to attain target blood pressure levels despite adequate use of at …

Hypertension remains a major public health problem and one of the most relevant causes of
cardiovascular mortality and morbidity worldwide. Roughly 10% of hypertensive individuals …

Background Renal nerve ablation (RNA) emerged as new therapeutic approach for
treatment resistant hypertension. Measurement of the renal and sympathetic activity …

Renal sympathetic nerves contribute to the development, maintenance and progression of
hypertension and related target organ damage. Both efferent and afferent renal nerve …